Skip to content
OpenCapital
Get started

Kodiak Sciences Inc KOD Cash ratio

Cash ratio at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
0.6×-0.3×
HRO
HarrowHROW
1×+0.7×
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
3.4×0.0×
Ocular Therapeutix logo
Ocular TherapeutixOCUL
14×+4.8×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
3.8×-2.3×
Vera Therapeutics logo
Vera TherapeuticsVERA
2.5×0.0×

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.32B+1,477%
Enterprise value$2.2B+2,798%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Calculated from Kodiak Sciences Inc’s reported figures.

cash and equivalents/total current liabilities=3.4×

Based on the most recent quarter.

The official record: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kodiak Sciences Inc's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kodiak Sciences Inc's cash ratio?
Kodiak Sciences Inc (KOD) reported cash ratio of 3.4× in Q1 2026.
How has Kodiak Sciences Inc's cash ratio changed year-over-year?
Kodiak Sciences Inc's cash ratio decreased by 24.0% year-over-year, from 4.5× to 3.4×.
What is the long-term trend for Kodiak Sciences Inc's cash ratio?
Over 5 years (2020 to 2025), Kodiak Sciences Inc's cash ratio has grown at a -31.3% compound annual growth rate (CAGR), from 30.1× to 4.6×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.